TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Ball speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: opioid craving
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: detoxification completion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tolerance of sanitary pads
Endpoint domain: Adverse events/effects
Primary endpoint: Satisfaction with sanitary pads
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean URTI scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean number of days rated as 'ill with URTI'
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time spent on anticoagulant therapy prior to cardioversion
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Thrombin generation levels (F1+2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Eating behavior patterns
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of psychiatric disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: patient-reported outcomes of participation
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: mean difference in the quickDASH
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Time to return of bowel movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Fugle‐Meyer motor function score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean time spent in post-anesthesia recovery room
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: PPG area under the curve (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: success rate of therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: minimal pain within 48 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: subjective function
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: RSOD prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Priapism frequency reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of coughing during the perioperative period
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of patients able to resume normal activities on the first postoperative day
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Knee joint proprioceptive acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Limits of stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in femoral neck BMD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Carotid extra-medial thickness (EMT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: non-HDL-C goal attainment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Lipid outcomes
Primary endpoint: Apolipoprotein B (ApoB) <90 mg/dL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Lipid outcomes
Primary endpoint: HDL-C >40/50 mg/dL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Lipid outcomes
Primary endpoint: decrease of IOP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrence rate within one year
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in assessment knowledge
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Enhancement of pharmacological knowledge
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Serum concentration of NSE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Hospitalization rate for infection
Endpoint domain: Adverse events/effects
Primary endpoint: Doctor visits
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: TB incidence rates
Endpoint domain: Mortality/survival
Primary endpoint: sleepiness score
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: energy/vitality domain
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: carotid-femoral PWV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: drop in heart rate (HR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of primary failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vocational reintegration rate
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: isokinetic plantarflexion strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Release of creatine kinase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Absolute mass of the area of hyperenhancement (infarcted tissue)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean change from baseline in Gracely Pain Scale score for average pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change from baseline scores on the Visual Analogue Scale for Pain Intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change from baseline scores on the McGill Pain Assessment Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: proportion of histopathological specimens with clear resection margins
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PF glutathione concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: blood flow in the choroid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: blood flow in the ONH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Change in NRS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Achievement rates of target range of calcium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: time for hemostasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: AEP component latencies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Primary events of ASCVD
Endpoint domain: Mortality/survival
Primary endpoint: Atrial fibrillation burden
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum glucose responses postprandially
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: hunger and desire to eat
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: days not feeling well
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: pinhole visual acuity of 6/18 or better
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: bone marrow toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: P. falciparum incidence in the 12 months after MDA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Number of patients independent after 3 months
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: pain reduction under lidocaine vs placebo
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of infusion-related reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Development of antidrug antibodies
Endpoint domain: Adverse events/effects
Primary endpoint: PpIX formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: treatment efficacy of BCCs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative survival at 1.5 years
Endpoint domain: Mortality/survival
Primary endpoint: Interrater and intrarater reliability of TrA muscle thickness measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: head stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: head velocity magnitudes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of opioid-negative urine samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative distribution function (CDF) of no illicit opioid use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retention in care at 6 weeks postpartum
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Perfect adherence to ARVs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with positive smears on day 3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: treatment continuation rate
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: 2,3-dinor-6-keto-PGF(1alpha) excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 11-dehydro-TXB(2) excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in coronal Cobb angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative hearing improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Irritability subscale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RD and MD values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: FA value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Pain score during uterine curettage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IGF‐I/IGFBP‐3 ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Leukocyte removal rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Production of interleukin-8
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Amount of post-operative wound drainage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Platelet function changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: overall quality of the related images acquired during TEE examination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NIH-CPSI score for QOL
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: SF-12 physical capacity score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Normalization of bone turnover
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in total MADRS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: morphine requirements in the first 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: treatment utilization
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Time to eligibility for extubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative pain scores during the first hour of weaning
Endpoint domain: Adverse events/effects
Primary endpoint: Response to LSD vs ESD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response after recovery sleep vs sleep deprivation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: receptive vocabulary
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: intellectual awareness levels
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: prediction online awareness
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Improvement in liver function parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: student performance in live rabbit surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Full remission achievement (HAM-D <= 7)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximum decrease of uric acid concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Risk of BE (Barrett's Esophagus)
Endpoint domain: Mortality/survival
Primary endpoint: Risk of EAC (Esophageal Adenocarcinoma)
Endpoint domain: Mortality/survival
Primary endpoint: LSM change in HbA1c
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of drug-related AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Mean daily blood glucose (BG) recorded
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cerebral microembolization (MCA microembolic signals)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Platelet function analysis (closure times on collagen)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Ground Reaction Forces (GRFs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Force Development
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Demonstration of the terminal ileum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Percentage of patients not smoking at follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TOM activity subscale improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: low density lipoprotein cholesterol (LDL-C) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: psychological improvement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: fatigue control
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Epinephrine concentration after endoscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time to Flatus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Flatus to Stool Flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Defecation Period
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Improvement in FIM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean diagnostic accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall infectious complications rate
Endpoint domain: Adverse events/effects
Primary endpoint: Satisfaction with the approach
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Reduction in total recoverable streptococci
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Reduction in S. mutans in plaque
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Reduction in streptococci in saliva
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: social communication improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: communication, daily living, and social skills stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: receptive language skills improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rebleeding within 30 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Seizure frequency per 28 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Response rates defined as a ≥50% reduction in seizure frequency per 28 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: microleakage at the composite/wire interface
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cerebrospinal fluid osmolarity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: patient-reported visual function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: visual symptoms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: impact of treatment administration
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Successful rate of intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Rate of successful intubation on the first attempt
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: food intake in neutral condition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in frequency of pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tumour regression 1 year after treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: incidence of vaginal cuff infection
Endpoint domain: Adverse events/effects
Primary endpoint: incidence of urinary tract infection
Endpoint domain: Adverse events/effects
Primary endpoint: Patient satisfaction with insulin administration method
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Continuation of insulin administration method at home
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: LDHA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RCF levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: SF levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Prevention of DVT
Endpoint domain: Adverse events/effects
Primary endpoint: ≥20% improvement in WOMAC pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ≥50% improvement in WOMAC pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MPCI response for WOMAC physical function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Affect during treadmill walk
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Affect during 2-min cool down
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: whiteness change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lightness change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximal walking distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percent change in mean arterial pressure reduction from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Procedural pain level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative CD3(+) immunocytes percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Postoperative CD4(+) immunocytes percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Postoperative IL-12 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Composite end point of death or heart failure (HF)
Endpoint domain: Mortality/survival
Primary endpoint: Hospitalizations for cardiac problems
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Intracranial Pressure (ICP) reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Glasgow Coma Scale (GCS) change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Weight regain percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Improvement on auditory training tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: resource utilization and costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: postoperative dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: disc dislocation prevalence
Endpoint domain: Adverse events/effects
Primary endpoint: skeletal relapse incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Maximal decrease in Ttym from preoperative baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for forced air warming for treatment of hypothermia
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Need for treatment with meperidine for severe shivering
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Tinnitus Severity Index (TSI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes